Try it
Pharmacology · Endocrine drugs: radioiodine and Graves ophthalmopathy
Sample itemA 40-year-old smoker with active Graves disease and moderate thyroid eye disease is planned for radioiodine. What measure reduces the risk of worsening of the eye disease?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Oral glucocorticoid cover around the radioiodine dose
Radioiodine can worsen thyroid eye disease, particularly in smokers with active disease, and a course of prednisolone given around the dose lowers this risk. Stopping smoking and restoring euthyroidism are also important.
Option by option
A. Starting high-dose potassium iodide after treatment
Iodide does not protect against orbitopathy and would compete with radioiodine uptake.
B. Oral glucocorticoid cover around the radioiodine dose (correct)
Correct. Steroid cover reduces the chance of orbitopathy worsening after radioiodine.
C. Giving radioiodine without any antithyroid drug
Omitting antithyroid drugs does not protect the eyes.
D. Stopping levothyroxine replacement for six months
He is not on levothyroxine, and stopping it is not a protective measure.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?